Edgemoor Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.29M | Buy |
22,924
+4,702
| +26% | +$1.91M | 0.8% | 35 |
|
|
2025
Q1 | $9.07M | Sell |
18,222
-169
| -0.9% | -$84.1K | 0.83% | 36 |
|
|
2024
Q4 | $9.57M | Sell |
18,391
-327
| -2% | -$170K | 0.84% | 31 |
|
|
2024
Q3 | $11.6M | Buy |
18,718
+125
| +0.7% | +$77.3K | 1.01% | 24 |
|
|
2024
Q2 | $10.3M | Buy |
18,593
+809
| +5% | +$447K | 0.96% | 27 |
|
|
2024
Q1 | $10.3M | Buy |
17,784
+2,115
| +13% | +$1.23M | 0.98% | 27 |
|
|
2023
Q4 | $8.32M | Buy |
15,669
+2,101
| +15% | +$1.12M | 0.87% | 29 |
|
|
2023
Q3 | $6.87M | Sell |
13,568
-1,755
| -11% | -$888K | 0.81% | 33 |
|
|
2023
Q2 | $7.99M | Buy |
+15,323
| New | +$7.99M | 0.9% | 30 |
|
|
2014
Q1 | – | Sell |
-96,032
| Closed | -$10.7M | – | 130 |
|
|
2013
Q4 | $10.7M | Sell |
96,032
-1,720
| -2% | -$192K | 1.7% | 19 |
|
|
2013
Q3 | $9.01M | Sell |
97,752
-2,171
| -2% | -$200K | 1.57% | 27 |
|
|
2013
Q2 | $8.46M | Buy |
+99,923
| New | +$8.46M | 1.5% | 26 |
|